tiprankstipranks
Resverlogix Corp. J (TSE:RVX)
TSX:RVX

Resverlogix (RVX) Stock Price & Analysis

27 Followers

RVX Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.05 - C$0.13
Previous CloseC$0.06
Volume36.00K
Average Volume (3M)36.53K
Market Cap
C$16.33M
Enterprise ValueC$25.44M
Total Cash (Recent Filing)$95.00K
Total Debt (Recent Filing)$6.77M
Price to Earnings (P/E)-1.2
Beta-0.20
Aug 09, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding274,816,238
10 Day Avg. Volume27,536
30 Day Avg. Volume36,527
Standard Deviation0.22
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.16
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)16.90
P/FCF Ratio5.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

48.22%0.00%<0.01%51.78%
48.22% Insiders
<0.01% Other Institutional Investors
51.78% Public Companies and
Individual Investors

RVX FAQ

What was Resverlogix Corp. J’s price range in the past 12 months?
Resverlogix Corp. J lowest stock price was C$0.05 and its highest was C$0.13 in the past 12 months.
    What is Resverlogix Corp. J’s market cap?
    Currently, no data Available
    When is Resverlogix Corp. J’s upcoming earnings report date?
    Resverlogix Corp. J’s upcoming earnings report date is Aug 09, 2024 which is in 82 days.
      How were Resverlogix Corp. J’s earnings last quarter?
      Currently, no data Available
      Is Resverlogix Corp. J overvalued?
      According to Wall Street analysts Resverlogix Corp. J’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Resverlogix Corp. J pay dividends?
        Resverlogix Corp. J pays a Notavailable dividend of C$0.4 which represents an annual dividend yield of N/A. See more information on Resverlogix Corp. J dividends here
          What is Resverlogix Corp. J’s EPS estimate?
          Resverlogix Corp. J’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Resverlogix Corp. J have?
          Resverlogix Corp. J has 272,171,330 shares outstanding.
            What happened to Resverlogix Corp. J’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Resverlogix Corp. J?
            Currently, no hedge funds are holding shares in TSE:RVX
            ---

            Resverlogix Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -53.84%
            12-Months-Change

            Fundamentals

            Return on Equity
            Trailing 12-Months
            Asset Growth
            -6.15%
            Trailing 12-Months

            Company Description

            Resverlogix Corp. J

            Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Nass Valley Gateway
            Reliq Health Technologies
            Microbix Biosystms
            Covalon Technologies
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis